Literature DB >> 31326467

The frequency of off-label prescribing in the treatment of dermatologic diseases during 2006-2015.

Brian Chu1, Alan Fleischer2, John S Barbieri3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31326467      PMCID： PMC6957718          DOI： 10.1016/j.jaad.2019.07.038

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Off-label prescribing in the treatment of dermatologic disease.

Authors:  Joel H Sugarman; Alan B Fleischer; Steven R Feldman
Journal:  J Am Acad Dermatol       Date:  2002-08       Impact factor: 11.527

2.  Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.

Authors:  John S Barbieri; Kayla St Claire; Arash Mostaghimi; Joerg Albrecht
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

3.  Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.

Authors:  John S Barbieri; William D James; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2017-07-01       Impact factor: 11.527

4.  Off-label prescribing: a call for heightened professional and government oversight.

Authors:  Rebecca Dresser; Joel Frader
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.